Kerstin Stein

Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues

Florian van Bömmel, Robert A. de Man, Heiner Wedemeyer et al. · Hepatology · 2009 · 330 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.

Katrina Wyatt, William Henley, Lindsey Anderson et al. · Health Technology Assessment · 2012 · 132 citations · Full text

Life Sciences, Pediatrics, Pharmacoeconomics +17

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Florian van Bömmel, Kerstin Stein, R Heyne et al. · Journal of Hepatology · 2023 · 92 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

The cost-effectiveness of testing for hepatitis C in former injecting drug users

E Castelnuovo, Jo Thompson Coon, Martin Pitt et al. · Health Technology Assessment · 2006 · 73 citations · Full text

Public Affairs, Health Policy, Pharmacoeconomics +16

Real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry

Tania M. Welzel, Holger Hinrichsen, Christoph Sarrazin et al. · Journal of Viral Hepatitis · 2017 · 46 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16